In silico evaluation demonstrates potential anticonvulsant activity of luteolin using molecular docking studies, suggesting new therapeutic avenues.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yamini et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: